Cargando…
Molecular profiling of Asian patients with advanced melanoma receiving check-point inhibitor treatment
OBJECTIVE: Melanoma is major medical challenge and being able to monitor treatment response is critical. This study aimed to use molecular profiling of Asian patients with advanced melanoma who were receiving treatment with check-point inhibitors (CPIs) to identify novel biomarkers of tumor response...
Autores principales: | Byeon, S., Cho, H.J., Jang, K.-T., Kwon, M., Lee, J., Kim, S.T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910729/ https://www.ncbi.nlm.nih.gov/pubmed/33399091 http://dx.doi.org/10.1016/j.esmoop.2020.100002 |
Ejemplares similares
-
HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors – a case report
por: Sumer, Johannes, et al.
Publicado: (2021) -
Immune Check Point Inhibitor–Associated Glomerulonephritis
por: Ashour, Tarek, et al.
Publicado: (2018) -
Immune Check Point Inhibitor–Associated Endothelialitis
por: Bobart, Shane A., et al.
Publicado: (2020) -
Targeted therapy of ovarian cancer including immune check point inhibitor
por: Kim, Jin Young, et al.
Publicado: (2017) -
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients
por: O’Byrne, K.J., et al.
Publicado: (2022)